Skip to main content

Table 1 Overview of HIV-1 sequences used in the analyses.

From: Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs

Type of genome

Group

Subtype

Reference sequences#

Non-reference sequences*

Total (Global HIV-1 population^)

Non - recombinant

M group

A

-

6

6

 

A1

4

46

50

 

A2

3

-

3

 

B

5

158

163

 

C

4

350

354

 

D

4

32

36

 

F1

4

6

10

 

F2

4

-

4

 

G

4

12

16

 

H

3

-

3

 

J

3

-

3

 

K

2

-

2

 

M - Total

40

610

650

 

N group

 

3

2

5

 

O group

 

4

13

17

N & O Total

7

15

22

Non-recombinants - Total

47

625

672

Circulating Recombinant Forms (CRF)

43

263

306

Total

90

888

978

  1. The table shows numbers of HIV-1 sequences of different subtypes among reference sequences and global population used in the analyses.
  2. # Reference sequences used in the primary analyses to identify association rules
  3. * Non-reference sequences were collected from 2008 Web alignment of HIV Sequence database
  4. ^ Total number of sequences in the global HIV-1 population used in the analysis